Stock Price Quote

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1343.3534.55 (+2.64 %)
PREV CLOSE ( ) 1308.80
OPEN PRICE ( ) 1310.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 137257
TODAY'S LOW / HIGH ( )1272.40 1404.55
52 WK LOW / HIGH ( )1169.75 3596.7
NSE1338.5531.7 (+2.43 %)
PREV CLOSE( ) 1306.85
OPEN PRICE ( ) 1310.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1338.55 (1648)
VOLUME 2824623
TODAY'S LOW / HIGH( ) 1272.05 1404.60
52 WK LOW / HIGH ( )1167 3598
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978
Management Info
Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 30510999

Email gland@glandpharma.com/investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

27Jan Gland Pharma informs about analyst meet
Pursuant to Regulation 30 read with Part A of the Securities and Exchang..
27Jan USFDA conducts inspection at Gland Pha
The United States Food and Drug Administration (USFDA) has conducted an..
25Jan Gland Pharma shines despite reporting
Gland Pharma is currently trading at Rs. 1424.30, up by 67.30 points or..
24Jan Gland Pharma reports 15% fall in Q3 co
Gland Pharma has reported results for third quarter ended December 31, 2..
07Jan Gland Pharma’s arm inks share purchase
Gland Pharma's wholly owned subsidiary -- Gland Pharma International PTE..

Financials

in Millions
QTR Dec 22 ANNUAL 22
Net Profit2275.3612121.55
Gross Profit 3052.4 16190.43
Operating Profit 3454.6717345.79
Net Sales 9258.9944007.08

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  21270.20 (1.49%)
M.Cap ( in Cr)45011.23
Alkem Laboratories (BSE)
peergroup  3178.00 (3.67%)
M.Cap ( in Cr)38039.60
Astrazeneca Pharma I (BSE)
peergroup  3333.00 (2.90%)
M.Cap ( in Cr)8315.13
Divi's Lab (BSE)
peergroup  2800.35 (1.86%)
M.Cap ( in Cr)74340.49
Dr. Reddy's Lab (BSE)
peergroup  4486.30 (1.00%)
M.Cap ( in Cr)74685.85

Shareholding Pattern

PROMOTERS 57.86%
FI/BANKS/INSURANCE 2.59%
MUTUAL FUNDS/UTI 19.49%
NON-INSTITUTION 14.34%
FII 0.01%
GOVERNMENT 0%

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 1343.35. Its current market capitalisation stands at Rs 22123.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 44007.08 Cr and Total Income of Rs.46246.48 Cr. The company's management includes Allen Zhang, Yao Fang, Qiyu Chen, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Udo Jahannes Vetter, Naina Lal Kidwai, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)